2008

Dangerous AIDS Policy: Drug patents are not the problem.
Wall Street Journal - November 30, 2008
Thompson Ayodele
LAGOS, Nigeria Today, as we mark World AIDS Day, we should take stock of the suffering this disease continues to inflict, particularly in developing countries. Twenty-five years after the disease was first discovered, AIDS continues to claim around two million lives each year. As an African, I ve witnessed the sufferin


Absent Vaccine, a New AIDS Debate
Wall Street Journal - November 26, 2008
Jacob Goldstein, jacob.goldstein@wsj.com
With a viable AIDS vaccine still years away at best, researchers are looking to existing drugs in the fight to slow the spread of the epidemic. The drugs appear to make transmission less likely by lowering the amount of HIV in the body, raising the possibility that the main weapon for treating the disease could be turn


A Big Shift for China's AIDS Fight: Condoms for Those Who Need Them
Wall Street Journal - November 18, 2008
Nicholas Zamiska and Geoffrey A. Fowler
BEIJING -- AIDS, which has long thrived quietly on the fringes of Chinese society among drug addicts and recipients of tainted blood donations, is on the verge of going mainstream here. One major cause is prostitution, a booming industry in China that has helped make sex the most common form of AIDS transmission in Chi


An HIV Vaccine Lab Lands on the Brooklyn Waterfront
Wall Street Journal Blog - November 13, 2008
Posted by Jacob Goldstein
The Health Blog hopped a water taxi yesterday to the old Army Terminal in Sunset Park, Brooklyn. It was a business trip: Some luminaries in HIV-vaccine research were gathered there to open a new lab. The center, a research hub for the International Aids Vaccine Initiative, is something of a big deal for New York City,


A Doctor, a Mutation and a Potential Cure for AIDS: A Bone Marrow Transplant to Treat a Leukemia Patient Also Gives Him Virus-Resistant Cells; Many Thanks, Sample 61
Wall Street Journal - November 7, 2008
Mark Schoofs, mark.schoofs@wsj.com
The startling case of an AIDS patient who underwent a bone marrow transplant to treat leukemia is stirring new hope that gene-therapy strategies on the far edges of AIDS research might someday cure the disease. The patient, a 42-year-old American living in Berlin, is still recovering from his leukemia therapy, but he a


Drug Firms Target Newly Rich Abroad
Wall Street Journal - November 5, 2008
Shirley S. Wang at shirley.wang@wsj.com and Jeanne Whalen at jeanne.whalen@wsj.com
As prescription-drug sales slow in the U.S. and other developed markets, pharmaceutical makers are increasingly targeting countries like Brazil , Russia , India and China , where rising prosperity has produced new customers willing to pay near U.


Review & Outlook: A Prize for Hu Jia - A model of courage in the face of Beijing's oppression.
Wall Street Journal - October 27, 2008
The European Parliament s awarding last week of its annual Sakharov Prize for Freedom of Thought to Chinese dissident Hu Jia is a positive step in more ways than one. The award honors particular achievement in . . . defense of human rights and fundamental freedoms, particularly the right to free expression. Mr. Hu is s


Jailed Dissident in China Wins Human-Rights Award
Wall Street Journal - October 24, 2008
Geoffrey A. Fowler, geoffrey.fowler@wsj.com
HONG KONG -- A prominent jailed Chinese dissident won a human-rights award given by European lawmakers, just as the continent s leaders get ready to meet with their Chinese counterparts and other Asian officials in Beijing this weekend. The move could lead to tense meetings between the leaders, who are expected to disc


Gates Foundation Seeks Out Nontypical Research to Fund
The Wall Street Journal - October 23, 2008
Robert A. Guth, rob.guth@wsj.com
The Bill & Melinda Gates Foundation will give $100 million in small doses to researchers doing novel medical-research experiments -- part of a new way to use the Web to reach medical researchers who might be missed in a traditional grant-selection process. The Gates foundation, the world s largest private philanthr


The Next Steps to Take in Beating AIDS: We're still making progress on drugs and vaccines.
Wall Street Journal - October 21, 2008
Luc Montagnier
In September 1983, data accumulated in my laboratory at the Pasteur Institute showed that a virus isolated in January of the same year was the best candidate to be the cause of AIDS. The discovery of human immunodeficiency virus (HIV) was the collective effort of a team of virologists, immunologists, molecular biologis


Paying Workers to Go Abroad for Health Care
Wall Street Journal - September 30, 2008
M.P. McQueen, mp.mcqueen@wsj.com
Insured Americans are starting to see some unusual options in their health-provider networks: doctors and hospitals in Singapore , Costa Rica and other foreign destinations. In an effort to control rising costs, a small but growing number of insurers and employers are giving people the choice to seek treatment in other


Big Guns Enter Malaria Fight: Alliance Gathers $3 Billion To Combat Deadly Disease
Wall Street Journal - September 26, 2008
Robert A. Guth, rob.guth@wsj.com
The fight against malaria, which kills one million of the 300 million people it infects every year, has been marked by high-profile battles that lapsed after surges of success. In the past five years, a new effort to stem the long-neglected mosquito-borne disease has begun to muster the essential elements for ending it


U.S. Drug Ban Hits Ranbaxy, Indian Maker of Generics
Wall Street Journal - September 17, 2008
Alicia Mundy, alicia.mundy@wsj.com; Jared A. Favole, jared.favole@dowjones.com; and Shirley S. Wang, shirley.wang@wsj.com
The U.S. Food and Drug Administration banned imports of more than 30 generic drugs made by India s Ranbaxy Laboratories Ltd., citing concerns about the safety of the company s production practices. The ban affects low-cost versions of popular medicines such as the anticholesterol drug Zocor;


Food Costs Feed Health Woes: For Many Relying on Nutritional-Support Groups, Better Diet Is Getting Too Expensive
Wall Street Journal - September 2, 2008
Joe Barrett, joseph.barrett@wsj.com
After peeling the electronic probes off Sharon Spain s foot and hand, Courtney Jones delivered the good news. You ve lost four pounds of body fat, said Ms. Jones, a clinical dietitian at Vital Bridges, a local nonprofit serving low-income people with HIV and AIDS. Call the police! said Ms. Spain, between puffs of oxyge


Glaxo's HIV-Drug Ads Draw Critics
Wall Street Journal - August 25, 2008
Jeanne Whalen
GlaxoSmithKline PLC, one of the biggest sellers of drugs to fight the AIDS virus, is drawing criticism over magazine ads in the U.S. that patient-support groups say attempt to scare patients away from trying newer drug regimens. Bob Huff, antiretroviral project director at Treatment Action Group, an advocacy group in


Patients Fear Their Rapport With Genentech Is in Danger
Wall Street Journal - August 14, 2008
Marilyn Chase, marilyn.chase@wsj.com
While Roche Holding AG s recent bid for Genentech Inc. cheered investors, it had a more chilling effect on the patient advocates who have developed unusually close ties to the pioneering biotechnology company. Despite contentious battles over the price of the cancer drugs it has developed over the past three decades, G


AIDS Anthology Reveals Another India
Wall Street Journal Blog - August 8, 2008
Posted by Marilyn Chase
At every International AIDS Conference, set apart from the meeting halls where science and politics battle, there s a place called the Global Village. It s a fleeting community where HIV-positive people and their advocates create a week-long DMZ free of stigma. The vibe is equal parts cultural exhibition and carnival s


Backlash Brews Against AIDS Support
Wall Street Journal Blog - August 7, 2008
Posted by Marilyn Chase
Right now we re seeing a backlash against AIDS, longtime AIDS activist Gregg Gonsalves declared in a plenary address today at the 17th International AIDS Conference in Mexico City. Some health and development specialists are arguing over the attention paid to the disease. AIDS, some say, is exaggerated as a threat, AID


NIH's Fauci Finds Hope Amid Challenges in AIDS Research
Wall Street Journal Blog - August 7, 2008
Posted by Marilyn Chase
The NIH s Anthony Fauci, who once cautioned that there might never be a traditional vaccine to prevent HIV infection and recently pulled the plug on a troubled vaccine trial, sounded a cautiously optimistic note at the 17th International AIDS Conference yesterday. The future for AIDS research looks bright and promising


Resistant TB Still Curable With Aggressive Treatment
Wall Street Journal - August 7, 2008
Keith J. Winstein, keith.winstein@wsj.com
The deadliest form of tuberculosis is still curable if properly treated, according to a new study that lifts hopes in the battle against bacterial infections impervious to common antibiotics. Drug-resistant strains of tuberculosis have caused alarm in public-health circles by raising the prospect of a deadly disease th


Wider Use of AIDS Drugs Could Curb HIV Infections
Wall Street Journal Blog - August 6, 2008
Posted by Marilyn Chase
Some drug experts at the 17th International AIDS Conference in Mexico City say countries should vastly expand drug treatment to all in need. Not only because relief from suffering is a human right, but because using drugs to lower the amount of HIV in infected people s blood on a massive, population-wide scale may lowe


AIDS Vaccine Strategy Needs a Makeover
Wall Street Journal Blog - August 6, 2008
Posted by Marilyn Chase
It s time to get over the flaws that felled the early crops of experimental AIDS vaccines and move to more fertile scientific ground, according to Seth Berkley, head of the International AIDS Vaccine Initiative. Berkley told the Health Blog it s time to abandon the majority of vaccines now under development, which copy


Clinton on AIDS: 'We Should Do More At Home'
Wall Street Journal Blog - August 5, 2008
Posted by Jacob Goldstein
Bill Clinton, who has made fighting AIDS in the developing world a central theme of his post-presidency, called for more effort to fight the disease in the U.S. He spoke yesterday at the big international AIDS conference on now in Mexico City. Earlier at the conference, the CDC said it had been radically undercounting


Clinton Urges More AIDS Efforts
Wall Street Journal - August 5, 2008
Marilyn Chase, marilyn.chase@wsj.com
MEXICO CITY -- Former U.S. President Bill Clinton, fresh from a tour of his foundation s projects in Africa, took the stage of the International AIDS Conference here to tell thousands that we must do more. AIDS is a big dragon, Mr. Clinton said Monday, but unlike the mythical dragon slain by St. George, this dragon mus


Honduran Girl Electrifies AIDS Meeting
Wall Street Journal Blog - August 4, 2008
Posted by Marilyn Chase
The titled and powerful who opened the 17th International AIDS Conference Sunday night amid mariachis and folkloric dance were all but upstaged by a girl in braces. Keren Dunaway-Gonzalez, a 12-year-old Honduran who earlier fought a case of nerves amid a press room scrum, took a breath and steadied her voice to tell se


CDC Criticized for Delays in Release of AIDS Data: Activists Say Chance Was Lost to Counter Impact of More Cases
Wall Street Journal - August 4, 2008
Marilyn Chase
MEXICO CITY -- Activists voiced anger over delays in the release of a report that the number of people infected with AIDS in the U.S. each year is likely 40% higher than previously estimated. [Chart] The Centers for Disease Control and Prevention said at a conference here that 56,300 people in the U.S. are likely infec


Big AIDS Parley Tries To Get Past Setbacks
Wall Street Journal - August 2, 2008
Marilyn Chase
American scientists gathering for the 17th International AIDS Conference say vaccines remain an important area of study in attacking the disease, despite recent setbacks, and they are also excited by other potential preventive steps such as a daily dose of antiviral drugs. The past two years have featured frustrations


Generics Fuel AIDS Program As U.S. Plan Shifts, Indian Drug Makers Reap the Benefits
Wall Street Journal - July 31, 2008
Sarah Lueck, sarah.lueck@wsj.com
WASHINGTON -- Companies that make generic drugs, many based in India , now dominate President George W. Bush s program to provide AIDS treatment in poor countries. Generic drugs, copies or combinations of brand-name products, accounted for 57% of the $131 million the U.S. spent on the program in fiscal 2007, according


U.N. Sees Peak in Infections With HIV
Wall Street Journal - July 30, 2008
Marilyn Chase, marilyn.chase@wsj.com
The AIDS pandemic has peaked or stabilized in some of the worst-hit countries, but is rising in others and remains volatile, a United Nations agency said. The report issued Tuesday, the most comprehensive to date by the Joint United Nations Programme on HIV/AIDS, included data from 147 countries. It estimated that 2.7


GlaxoSmithKline Continues To Battle Slow Growth
Wall Street Journal - July 23, 2008
Jeanne Whalen, jeanne.whalen@wsj.com
GlaxoSmithKline PLC reported weak second-quarter earnings as it laid out additional changes to its drug-research team and announced an alliance with a company that sells low-cost medicines in emerging markets. The world s second-largest drug company by sales, after Pfizer Inc., will also


California Balks at Paying Billions to Improve Prison Health Care
Wall Street Journal - July 21, 2008
Bobby White, bobby.white@wsj.com
A federally appointed receiver assigned to fix the prison health-care system in California says he will force the state to come up with $2.5 billion to begin improvements -- just as legislators are confronting a budget shortfall of over $15 billion this fiscal year. State legislators have failed to approve funds to com


U.S. Scraps Plan to Test AIDS Vaccine
Wall Street Journal - July 18, 2008
Marilyn Chase, marilyn.chase@wsj.com
The U.S. National Institutes of Health scrubbed plans to test its AIDS vaccine due to concerns about its safety and effectiveness, 10 months after the collapse of a clinical trial for a similar vaccine from Merck & Co. Thursday s move, the latest setback in a field pummeled by recent failures, is a sober recognitio


Gilead's Net Income Rises 8.6% On Strong Antiviral Drug Sales
Wall Street Journal - July 17, 2008
Andrew Edwards And Lauren Pollock
Gilead Sciences Inc. s second-quarter net income rose 8.6% on strong sales of the company s antiviral drugs. The biotechnology company reported net income of $442.8 million, or 46 a share, compared with $407.9 million, or 42 a share, a year earlier. Excluding stock-based compensation and certain research and developm


Untying a Genetic Knot
Wall Street Journal - July 17, 2008
Gautam Naik, gautam.naik@wsj.com
In that oldest and deadliest of wars, between man and microbe, scientists are starting to unearth clues about a key battleground: the human genome. In an intriguing piece of research, scientists have found that an ancient genetic variation that once protected people of African descent against a certain type of malaria


Patients Curb Prescription Spending: Already Ailing, Drug Industry Takes Hit On Higher-Priced Brand Name Medicine
Wall Street Journal - July 16, 2008
Shirley S. Wang and Avery Johnson, avery.johnson@WSJ.com
In an ominous sign for drug makers, the number of prescriptions dispensed by pharmacies in the U.S. is growing at its worst rate in at least a decade as consumers are squeezed by both a troubled economy and the growing burden of out-of-pocket health-care costs. The pharmaceutical industry by conventional wisdom is resi


Ranbaxy Probe Extends to Africa Drugs
Wall Street Journal - July 15, 2008
John R. Wilke at john.wilke@wsj.com
WASHINGTON -- Ranbaxy Inc., India s largest pharmaceutical company and among the world s biggest generic-drug makers, faces a U.S. investigation into whether it manufactured substandard generic drugs, including allegations that it made weak or adulterated HIV drugs that were given to thousands of AIDS patients in Afric


MAIN STREET (OP/ED): The U.S. Keeps Its Global Commitments
Wall Street Journal - July 8, 2008
William McGurn, MainStreet@wsj.com
If you ve ever been through a G-8 Summit, right about now you re probably feeling like Bill Murray in Groundhog Day. That s the one where he plays a man forced to live the same day over and over. In much the same way, G-8 meetings follow a familiar script year after year. They begin with leaders issuing lofty statement


Agency to Unveil TB Test That Speeds Detection
Wall Street Journal - July 1, 2008
Marilyn Chase, marilyn.chase@wsj.com
The World Health Organization and its funding partners said they plan to roll out a $26 million program to distribute a new gene-based test that detects multidrug-resistant tuberculosis after just two days rather than the weeks or months typical of existing tests. The WHO and UNITAID, a multinational funding partnershi


Drug Makers Say FDA Safety Focus Is Slowing New-Medicine Pipeline
Wall Street Journal - June 30, 2008
Avery Johnson, avery.johnson@WSJ.com and Ron Winslow, ron.winslow@wsj.com
Nearly four years after Merck & Co. yanked the painkiller Vioxx off the market, beleaguered pharmaceutical-industry executives say they are facing a tough new regulatory climate that is altering the landscape of drug development. Over the past 16 months, Schering-Plough Corp. Chief Executive Fred Ha


EDITORIAL: Coburn of Africa
Wall Street Journal - June 28, 2008
In fighting HIV/AIDS in Africa, the United States has an unparalleled success in Pepfar, aka the President s Emergency Plan for AIDS Relief. Since President Bush announced it in 2003, Pepfar has provided antiretroviral drugs to nearly 1.4 million infected patients in its target countries, turning the wasted shells of c


Problems -- and Solutions: Melinda Gates on how the Gates Foundation sets its priorities in a world filled with challenges
Wall Street Journal - June 9, 2008
Melinda French Gates is co-chair of the Bill and Melinda Gates Foundation, as well as the wife of Microsoft Chairman Bill Gates. Together, they head the world s largest charitable foundation, tackling such problems as public-health issues in Africa, India and elsewhere and the U.S. public-school system. She talked


Melinda Gates defines a charity's mission: 'All lives are equal' as the basic tenet; applying analysis
Wall Street Journal - June 5, 2008
Robert A. Guth, rob.guth@wsj.com
HIV-AIDS, malaria, tuberculosis, high-school dropouts and global poverty. Those are among the problems that Melinda Gates is battling with the huge fortune her husband Microsoft Chairman Bill Gates made in technology. At an appearance at the D: All Things Digital conference last week in California, Ms. Gates explained


Good Medicine for Thailand
Wall Street Journal - May 29, 2008
Slowly, the war on drug patents in Thailand seems to be turning. Last week the government removed one of the most vocal opponents of intellectual property rights from the board of the state-owned Government Pharmaceutical Organization. It s a small step, but an important one for restoring Thailand s international reput


OPINION: Grassley's War on Cancer Patients
Wall Street Journal - May 29, 2008
Mark Thornton**
The news did not make it to the front pages, but on Feb. 28 a powerful member of the U.S. Senate launched an attack on the Food and Drug Administration, the drug companies and the desperate cancer patients they treat. Charles Grassley (R., Iowa), ranking member of the Senate Finance Committee, requested that the Govern


Antiabortion Groups Push Bush on Clinics' Subsidies
Wall Street Journal - May 23, 2008
Stephanie Simon, stephanie.simon@wsj.com
With time running out on the Bush administration, conservative activists are renewing a drive for regulations that would deny federal subsidies to clinics that provide abortions or counsel women about the option. In a final push, the activists are preparing a public campaign to pressure President Bush to use his execut


OPINION: The Tragedy of Thabo Mbeki
Wall Street Journal - May 21, 2008
Barney Mthombothi*
JOHANNESBURG, South Africa Thabo Mbeki often seems happier when he s away from home, putting out fires in other African countries. An increasing number of his compatriots wish the South African president would just go away, never to come back. Mr. Mbeki has become so unpopular that even members of his own party want hi


Market Is Down; Is Giving, Too? Charity Gala Organizers Have Lower Expectations For This Year's Big Event
Wall Street Journal - May 13, 2008
Cassell Bryan-Low
London s hedge-fund elite are awaiting one of the biggest social events of the year: the ARK charity dinner. Given the difficult start to the year for the markets, organizers aren t expecting to match the (pounds)26.6 million ($51.9 million) they raised in 2007. Arpad Busson, founder of both children s charity ARK, whi


Octogenarian Activism
Wall Street Journal - April 30, 2008
Leslie Hook
BEIJING - Dissent is usually associated with hot-blooded youth. But protest is not just for the young. Nowhere is this more true than China , where the country s most effective political activists are a generation of septa- and octogenarians. As Confucius said, At 70, I could follow what my heart desired, without overs


McCain Pushes a Health-Care Plan With Less Regulation
Wall Street Journal - April 30, 2008
Laura Meckler, laura.meckler@wsj.com
TAMPA, Fla. -- Sen. John McCain laid out his vision for the U.S. health-care system Tuesday, rejecting universal health insurance and embracing a system with fewer regulations in which consumers shop for coverage on their own rather than get it from an employer. His plan, parts of which are similar to a failed effort b


Clinton Foundation, Unitaid Strike Deals on Price Cuts for AIDS Drugs
Wall Street Journal - April 29, 2008
Marilyn Chase, marilyn.chase@wsj.com
The Clinton Foundation HIV/AIDS Initiative and the international drug-purchasing consortium Unitaid have struck deals that offer deeper discounts on more than 40 generic AIDS drugs and create child-friendly formulas for neediest victims of the pandemic. The new prices offered by three generic drug makers run 19% lower


We Are Making Progress on AIDS
Wall Street Journal - April 25, 2008
Seth Berkley
Scientists from all over the world recently have engaged in a searching conversation about where we stand on the development of an AIDS vaccine. If you ve heard about these discussions from media reports, chances are you think they judged it a mission impossible. Actually, there are sound scientific reasons to believe


Volunteering Overseas
Wall Street Journal - April 13, 2008
Emily Green
If you ve thought of spending some time doing volunteer work or teaching overseas, your twenties may be the time to pursue it. For many, the age offers a unique period of financial and personal independence -- free of children and entrenched professional careers. For some, time overseas can provide a respite from profe


COMMENTARY: THE WEEKEND INTERVIEW - Jacob Zuma: After Mandela
Wall Street Journal - April 5, 2008
Matthew Kaminski
Cape Town, South Africa - That s part of the problem in Europe – to think an African is just like another African. Jacob Zuma is talking about comparisons drawn between him and Robert Mugabe, the man who turned Zimbabwe s post-colonial dream into a nightmare. Then he laughs deeply, throwing his head back. In spite


Chinese Blogger and Rights Activist Sentenced to Prison for Subversion
Wall Street Journal - April 3, 2008
Sky Canaves, sky.canaves@wsj.com and Geoffrey A. Fowler, geoffrey.fowler@wsj.com
HONG KONG -- Hu Jia, an AIDS activist and blogger who used the coming Olympics to criticize China s record on human rights, was sentenced to three and a half years in prison on Thursday, after a Beijing court found him guilty of subversion and libel. The high-profile verdict heightens concerns among human-rights activi


Glaxo AIDS Drug Shows Heart Risk in Study
Wall Street Journal - April 3, 2008
LONDON -- A drug from U.K.-based GlaxoSmithKline PLC commonly used to fight AIDS appears to nearly double the risk of a heart attack, researchers said. In a study published online in The Lancet medical journal, European researchers said that the antiretroviral abacavir , which is


Progress Made in HIV Surveillance
Wall Street Journal - March 31, 2008
New data from the Centers for Disease Control and Prevention show the number of people in the U.S. diagnosed with HIV in 2006 to be sharply higher than in previous years, reflecting the agency s improved surveillance system rather than a rise in the epidemic. The figures give a more accurate picture of the disease acro


CDC Data Show Rise in HIV Cases, Reflecting More Accurate Tracking
Wall Street Journal - March 28, 2008
Betsy McKay, betsy.mckay@wsj.com
New data from the Centers for Disease Control and Prevention show the number of people in the U.S. diagnosed with HIV in 2006 to be sharply higher than in previous years, reflecting the agency s improved surveillance system rather than a rise in the epidemic. But the figures also give a more accurate picture of the dis


AIDS Scientist Calls for Basic Tack
Wall Street Journal - March 26, 2008
Marilyn Chase, marilyn.chase@wsj.com
The top AIDS scientist at the National Institutes of Health called for a shift back to basic vaccine research to address unanswered questions in the wake of the failure of a major AIDS vaccine trial last year. Addressing an AIDS Vaccine Summit in Bethesda, Md., Anthony S. Fauci, director of the National Institute of Al


How Walgreen Changed Its Prescription for Growth
Wall Street Journal - March 19, 2008
Amy Merrick, amy.merrick@wsj.com
Walgreen Co. thrived for decades by opening stores faster than its competitors -- a new location pops up every 16 hours -- and by pushing out more prescriptions per year than any other chain. But facing pressure from rivals, a weak economy and cracks in the health system, Walgreen is changing its time-tested formula. I


THE INFORMED PATIENT: Hospitals Reuse Medical Devices To Lower Costs
Wall Street Journal - March 19, 2008
Laura Landro, laura.landro@wsj.com
In a bid to save costs and stem a rising tide of medical waste, hospitals are recycling a growing number of medical devices labeled as single-use, from scissors and scrubs to the sharp blades surgeons use to saw through bones. Recycling medical devices labeled for single use is legal as long as certain Food and Drug Ad


REVIEW & OUTLOOK: The Trial of Hu Jia
Wall Street Journal - March 18, 2008
As the National People s Congress draws to a close today, China s leaders probably won t be giving much thought to what s taking place in another corner of Beijing, at the No. 1 People s Intermediate Court. Events there may actually reveal more about the state of the nation s progress. Today, one of China s most outspo


Blunt Sermons Rooted in Black Tradition
Wall Street Journal - March 17, 2008
Suzanne Sataline, suzanne.sataline@wsj.com and Douglas Belkin, doug.belkin@wsj.com
CHICAGO -- Yesterday morning, 6,000 people streamed into Trinity United Church of Christ here for Palm Sunday services, where blunt, funny and often fiery sermons have made the church popular among African Americans and plunged it and Sen. Barack Obama into controversy in recent days. The Rev. Otis Moss III, the church


Thai Ministry to Recommend Ignoring Patents on Cancer Drugs
Wall Street Journal - March 11, 2008
Nicholas Zamiska, nicholas.zamiska@wsj.com
Thailand s new health minister announced that he would urge the Thai government to continue to ignore patents on several cancer drugs, disappointing big pharmaceutical companies that had hoped Bangkok might roll back a policy of overriding patents in the name of public health. The drugs makers include Roche Holding AG


Homeless Study Looks at 'Housing First': Shifting Policies to Get Chronically Ill in Homes May Save Lives, Money
Wall Street Journal - March 6, 2008
Joe Barrett
A four-year study of homeless people with chronic medical problems in Chicago offers fresh evidence that efforts to move the homeless into permanent housing quickly can improve their lives and save taxpayer money. The study was put together by a coalition of hospitals and housing groups seeking hard evidence supporting


REVIEW & OUTLOOK: Kenya and the World Bank
Wall Street Journal - March 6, 2008
Kenya s two month political crisis may finally be coming to a close with the announcement last week of a power-sharing deal between President Mwai Kibaki and challenger Raila Odinga. With some 1,000 dead and an estimated 600,000 people displaced since the disputed December 27 election, we can only hope the deal holds.


Bangkok's Drug War, Round Two
Wall Street Journal - February 27, 2008
Thailand s military government may be gone, but its war on drug patents is still very much alive. Just ask the new Health Minister, Chaiya Sasomsup, who is thinking about restoring intellectual property rights to their rightful owners -- the pharmaceutical companies. Mr. Chaiya, who took office this month, is trying to


THE DOCTOR'S OFFICE: The Patient Nobody Wanted
Wall Street Journal - February 26, 2008
Benjamin Brewer, M.D.
The snow fell in large, fluffy flakes for hours, enveloping everything in town in a thick silencing blanket of white. Our small town shut down for the evening. I was thankful because I don t get many calls after hours when it snows heavily. People stay put and the whole prairie landscape seems serene and beautiful.


President Invokes Religious Themes In Tour of Africa: Bush Touts Drugs' 'Lazarus Effect' on AIDS Victims
Wall Street Journal - February 17, 2008
John D. McKinnon, john.mckinnon@wsj.com
DAR ES SALAAM, Tanzania -- President Bush s current tour of Africa is widely viewed as a celebration of his historic efforts in battling poverty and disease here. But listen closely to Mr. Bush and his aides, and you might conclude that a higher power is at work -- and it s achieving near-miraculous results. This w


Bush to Trumpet African Successes as Crises Cast Shadows
Wall Street Journal - February 9, 2008
John D. McKinnon, john.mckinnon@wsj.com
President Bush starts a victory lap across Africa next week, celebrating his little-noticed but successful fights there against AIDS and malaria. But he also will be running hard to avoid the shadow of a growing number of political crises and controversies in the region. As Mr. Bush enters his final 12 months in office


New Tests Spot Infectious Bugs More Quickly
Wall Street Journal - February 5, 2008
Shirley S. Wang, shirley.wang@wsj.com
Hospitals are increasingly deploying a new breed of diagnostic tests -- ones that promise results in hours not days and are particularly effective in detecting deadly antibiotic-resistant superbugs. This new generation of tests identifies organisms using genetic information rather than growing them in a dish and examin


Yukos Ex-Chief Is on Hunger Strike
Wall Street Journal - January 31, 2008
Alan Cullison, alan.cullison@wsj.com
MOSCOW -- Imprisoned former oil tycoon Mikhail Khodorkovsky announced a hunger strike yesterday to protest authorities refusal to give AIDS treatment to a onetime colleague who is awaiting trial in a Moscow jail. Mr. Khodorkovsky s move ups the ante in an effort to draw attention to the plight of the colleague, who say


Pfizer Seeks to Prevent HIV
Wall Street Journal - January 30, 2008
Avery Johnson, avery.johnson@WSJ.com
A new Pfizer Inc. HIV drug will soon be reformulated in an effort to prevent the transmission of the virus, offering a faint ray of hope in an arena littered with disappointments. The New York drug maker is expected to announce today that it will license its new medicine, Selzentry, to a nonprofit that investigates way


Russian Court Upholds Ruling Of Tax Evasion Against PWC
Wall Street Journal - January 28, 2008
Gregory L. White, greg.white@wsj.com
MOSCOW -- A Russian court upheld a ruling that PriceWaterhouseCoopers LLC was effectively a participant in massive tax evasion by now-bankrupt oil giant OAO Yukos. The ruling ratchets up pressure on the auditor as the Kremlin gears up for more charges in the politically tinged Yukos case. Prosecutors have filed new all


FDA Procedures Draw Scrutiny: Vytorin, Avandia Rekindle Debate Over Drug-Approval Process
Wall Street Journal - January 25, 2008
Anna Wilde Mathews, anna.mathews@wsj.com and Ron Winslow, ron.winslow@wsj.com
Controversies about cholesterol drug Vytorin and diabetes drug Avandia are reigniting debate over what evidence the Food and Drug Administration requires to approve drugs -- and may generate pressure on the agency to raise its bar. The FDA s system for approving drugs has been criticized as scrutiny grows about Vytorin


Resistance of Superbug Grows: New MRSA Strain Hits Communities Of Gay Men Hardest
Wall Street Journal - January 15, 2008
Marilyn Chase, marilyn.chase@wsj.com
A highly drug-resistant superbug is gaining resistance to more drugs and burrowing deeply into the gay communities of San Francisco and Boston, researchers said. Sexually active gay men are 13 times as likely to have this strain of the highly resistant bacterium, known as MRSA, or methicillin-resistant staphylococcus a



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 2008. AEGiS.